Neoadjuvant Checkpoint Blockade in Lynch Syndrome-Related Pancreatic Adenocarcinoma

Pancreas. 2021 Feb 1;50(2):e22-e24. doi: 10.1097/MPA.0000000000001742.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / genetics
  • Adenocarcinoma / immunology
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Chemotherapy, Adjuvant
  • Colorectal Neoplasms, Hereditary Nonpolyposis / genetics*
  • Fatal Outcome
  • Humans
  • Male
  • Middle Aged
  • Neoadjuvant Therapy*
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / genetics
  • Pancreatic Neoplasms / immunology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab